Toxicology and Safety of Cannabis Products

Covers safety, toxicity, and adverse effect profiles of cannabinoids. Acute and chronic toxicity studies, drug interactions, and pharmacovigilance are discussed. Regulatory requirements for product safety and quality are highlighted. Risk assessment approaches and patient monitoring strategies are presented. Emerging trends in toxicological research and safety optimization are shared.

    Related Conference of Toxicology and Safety of Cannabis Products

    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 22-23, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore

    Toxicology and Safety of Cannabis Products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in